Okami Medical Announces First Patient Enrolled in ALPHA Registry

Okami Medical Announces First Patient Enrolled in ALPHA Registry

ALISO VIEJO, Calif., April 7, 2026 /PRNewswire/ -- Okami Medical, a medical technology company pioneering novel vascular embolization solutions, today announced the enrollment of the first patient in the ALPHA Registry, a prospective, multicenter registry evaluating the safety and effectiveness…

ALPHA Registry Studies Okami LOBO Vascular Occlusion System

April 8, 2026—Okami Medical announced the enrollment of the first patient in the ALPHA registry, a prospective, multicenter registry evaluating the safety and effectiveness of the company’s LOBO vascular occlusion system for patients with a variety of peripheral vascular conditions, including arterial hemorrhage and pulmonary arteriovenous malformation. Okami stated that the LOBO device is designed to provide controlled mechanical occlusion of p…